Quick Summary:
Emerging opportunities in the growing Critical Care Therapeutics market are clearly outlined in our latest market research report, giving you the insights needed to stay competitive while crafting your business strategy for the next decade. Providing an in-depth analysis of current trends and future projections, this report not only places the global market value at an estimated US$7.4 billion by 2030 but also emphasizes the role of key market segments like Albumin which is projected to record significant growth.
Detailed geographic analysis further emphasizes the potential in rapidly growing markets like China, along with a solid review of established markets such as the United States, Europe, Japan, and Canada. Highlighting the strategies and performances of prominent market players can provide a comprehensive understanding to drive your strategic planning. Moreover, the report offers timely updates on key market events and access to an online collaborative research platform, ensuring essential data and trends are always at your fingertips. This definitive Critical Care Therapeutics Market report is your ultimate guide to navigating the evolving landscape and identifying profitable pathways in this exciting sector.
Global Critical Care Therapeutics Market to Reach $7.4 Billion by 2030
The global market for Critical Care Therapeutics estimated at US$4.8 Billion in the year 2022, is projected to reach a revised size of US$7.4 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2022-2030. Albumin, one of the segments analyzed in the report, is projected to record 6.8% CAGR and reach US$3.7 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Prothrombin Complex Concentrates segment is readjusted to a revised 4.5% CAGR for the next 8-year period.The U.S. Market is Estimated at $1.3 Billion, While China is Forecast to Grow at 9% CAGR
The Critical Care Therapeutics market in the U.S. is estimated at US$1.3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.8 Billion by the year 2030 trailing a CAGR of 9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.1% and 4.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.Select Competitors (Total 37 Featured) -
- Abeona Therapeutics Inc.
- ADMA Biologics, Inc.
- Albumedix Ltd.
- Asklepios Biopharmaceutical, Inc.
- Aspen Pharmacare Holdings Ltd.
- Baxter International Inc.
- Bayer Healthcare AG
- Bio Products Laboratory Ltd.
- BioDelivery Sciences International, Inc.
- Biogen, Inc.
- BioMarin Pharmaceutical Inc.
- Biotest Pharmaceuticals Corporation
- Bristol-Myers Squibb Company
- Catalyst Biosciences, Inc.
- China Biologic Products Holdings, Inc.
- Cosmo Pharmaceuticals NV
- CSL Behring
- Grifols International SA
- Kamada Ltd.
- Kedrion Biopharma, Inc.
- Medxbio Pte. Ltd.
- Merck & Co., Inc.
- Mitsubishi Tanabe Pharma Corporation
- Novo Nordisk A/S
- Novozymes A/S
- Octapharma AG
- Portola Pharmaceuticals, Inc.
- ProMetic Life Sciences, Inc.
- rEVO Biologics, Inc.
- Rockwell Medical
- Sanquin
- Shanghai RAAS Blood Products Co., Ltd.
- Shire PLC
- Teva Pharmaceutical Industries Ltd.
- The Medicines Company
- Thermo Fisher Scientific, Inc.
- Ventria Bioscience
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Critical Care Therapeutics?
What is the growth rate of the Global Market for Critical Care Therapeutics?
What is the forecasted size of the Global Market for Critical Care Therapeutics?
Who are the key companies in the Global Market for Critical Care Therapeutics?
Report Attribute | Details |
---|---|
No. of Pages | 242 |
Published | December 2023 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 4.8 Billion |
Forecasted Market Value ( USD | $ 7.4 Billion |
Compound Annual Growth Rate | 5.6% |
Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Abeona Therapeutics Inc.
- ADMA Biologics, Inc.
- Albumedix Ltd.
- Asklepios Biopharmaceutical, Inc.
- Aspen Pharmacare Holdings Ltd.
- Baxter International Inc.
- Bayer Healthcare AG
- Bio Products Laboratory Ltd.
- BioDelivery Sciences International, Inc.
- Biogen, Inc.
- BioMarin Pharmaceutical Inc.
- Biotest Pharmaceuticals Corporation
- Bristol-Myers Squibb Company
- Catalyst Biosciences, Inc.
- China Biologic Products Holdings, Inc.
- Cosmo Pharmaceuticals NV
- CSL Behring
- Grifols International SA
- Kamada Ltd.
- Kedrion Biopharma, Inc.
- Medxbio Pte. Ltd.
- Merck & Co., Inc.
- Mitsubishi Tanabe Pharma Corporation
- Novo Nordisk A/S
- Novozymes A/S
- Octapharma AG
- Portola Pharmaceuticals, Inc.
- ProMetic Life Sciences, Inc.
- rEVO Biologics, Inc.
- Rockwell Medical
- Sanquin
- Shanghai RAAS Blood Products Co., Ltd.
- Shire PLC
- Teva Pharmaceutical Industries Ltd.
- The Medicines Company
- Thermo Fisher Scientific, Inc.
- Ventria Bioscience